CTL019 (tisagenlecleucel)

tisagenlecleucel · Novartis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CTL019 (tisagenlecleucel), covering 2017-02-14 to 2017-02-14. Get the full timeline:

Most recent: Clinical Trial Update: Study of Efficacy and Safety of CTL019 in Adult ALL Patients [Phase 2]